Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03

PURPOSE: To validate lysyl oxidase (LOX), a hypoxia-related protein, as a marker for metastasis in an independent head and neck cancer (HNC) patient group enrolled onto a prospective trial. PATIENTS AND METHODS: We performed traditional immunohistochemical (IHC) staining and automated quantitative a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Le, Quynh-Thu, Harris, Jonathan, Magliocco, Anthony M., Kong, Christina S., Diaz, Roman, Shin, Brian, Cao, Hongbin, Trotti, Andy, Erler, Janine T., Chung, Christine H., Dicker, Adam, Pajak, Thomas F., Giaccia, Amato J., Ang, K. Kian
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744270/
https://ncbi.nlm.nih.gov/pubmed/19667273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.6003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados